NCT06258863

Brief Summary

  1. 1.DATA COLLECTION: About 300 cases of female patients who underwent breast reconstruction at Hubei Cancer Hospital(HBCH) between February 2013 and June 2023 were retrospectively collected. The incision was defined as the mastectomy incision and was grouped by the commonly used inframammary fold incision, lateral chest wall incision, circumareolar incision, and radial incision. The incidence of postoperative incision-related complications was recorded for different incision types;
  2. 2.DATA ORGANIZATION: Patients were divided into subgroups based on history of previous breast surgery, location and size of the lump, retention of the nipple-areola complex, timing of reconstruction, and type of the implant. The correlation of each subgroup with incision design is discussed;
  3. 3.FOLLOW-UP: Collected cases were followed up by telephone to complete the Breast-Q questionnaire (aesthetic score);
  4. 4.DATA ANALYSIS: The incidence of postoperative incision-related complications and aesthetic scores for different incision types were statistically analyzed.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 18, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

January 15, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 14, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 18, 2024

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 18, 2025

Completed
Last Updated

March 17, 2025

Status Verified

November 1, 2024

Enrollment Period

1 year

First QC Date

January 15, 2024

Last Update Submit

March 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Breast-Q Version 2.0 Reconstruction Module

    The questionnaire was filled in by the subjects, and the researchers assigned scores according to the results of the questionnaire. scores of the following three parts were recorded according to the Breast-Q Version 2.0© reconstruction module, with higher scores indicating better aesthetic results, Psychosocial Well-being (0 to 100), Sexual Well-being (0 to 100), Satisfaction with Breasts (0 to 100)

    three months after surgery; six months after surgery; 1 year after surgery

Secondary Outcomes (1)

  • Incision-Related Complications

    within 1 year after surgery

Study Arms (4)

inframammary fold incision

A total mastectomy was performed using an inframammary fold incision

Procedure: incision type

lateral chest wall incision

A longitudinal incision was made in the lateral chest wall for a total mastectomy

Procedure: incision type

circumareolar incision

A total mastectomy was performed with an arc-shaped incision around the areola without limiting the distance to the nipple

Procedure: incision type

radial incision

A total mastectomy was performed with a radial incision around the nipple

Procedure: incision type

Interventions

incision typePROCEDURE

Total mastectomy was performed using one of the four incision types

circumareolar incisioninframammary fold incisionlateral chest wall incisionradial incision

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

About 300 female patients who underwent breast reconstruction at Hubei Cancer Hospital between January 2019 and September 2023 were collected.

You may qualify if:

  • total mastectomy
  • implant and/or autologous breast reconstruction.

You may not qualify if:

  • No total mastectomy
  • loss of data or loss of follow-up
  • fatal cases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hubei Cancer Hospital

Wuhan, Hongshan District, 430070, China

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Physician

Study Record Dates

First Submitted

January 15, 2024

First Posted

February 14, 2024

Study Start

July 18, 2023

Primary Completion

July 18, 2024

Study Completion

November 18, 2025

Last Updated

March 17, 2025

Record last verified: 2024-11

Locations